Product Name: Sermaglutide Intermediate

CAS: 1169630-82-3
Usage: For the treatment of diabetes and it can help to lose weight.
Advantages:
- Our Sermaglutide API is in Pilot production stage with production quantity 100g per batch.
- We will get DMF documents in early of 2023 ,and submit to FDA in the middle of 2023 for Sermaglutide API .
- Our sermaglutide API and intermediates are produced in GMP condition workshop, with high purity 99% up , single impurity below 0.1% by HPLC.
4) Competitive price compare with the original Novo Nordisk for API .
5) Sermaglutide is very new and good API for diabetes with very large market demand quantities.
6) Using advanced recombinant protease with Bio-enzyme technology to produce the intermediates of Sermaglutide ( main chain and side chain).
